Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk

Authors: Richard, Shambavi, Chari, Ajai, Delimpasi, Sosana, Simonova, Maryana, Spicka, Ivan, Pour, Ludek, Kriachok, Iryna, Dimopoulos, Meletios A., Pylypenko, Halyna, Auner, Holger W., Leleu, Xavier, Usenko, Ganna, Hajek, Roman, Benjamin, Reuben, Dolai, Tuphan Kanti, Sinha, Dinesh Kumar, Venner, Christopher P., Garg, Mamta, Stevens, Don Ambrose, Quach, Hang, Jagannath, Sundar, Moreau, Phillipe, Levy, Moshe, Badros, Ashraf, Anderson, Larry D., Bahlis, Nizar J., Facon, Thierry, Mateos, Maria Victoria, Cavo, Michele, Chang, Hua, Landesman, Yosef, Chai, Yi, Arazy, Melina, Shah, Jatin, Shacham, Sharon, Kauffman, Michael G., Grosicki, Sebastian, Richardson, Paul G.

Source: American journal of hematology. 96(9):1120-1130

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125675678.0x000001&indx=1&recIds=ETOCvdc_100125675678.0x000001

Effect of age and frailty on the efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma

Authors: Auner, Holger W., Gavriatopoulou, Maria, Delimpasi, Sosana, Simonova, Maryana, Spicka, Ivan, Pour, Ludek, Dimopoulos, Meletios A., Kriachok, Iryna, Pylypenko, Halyna, Leleu, Xavier, Doronin, Vadim, Usenko, Ganna, Hajek, Roman, Benjamin, Reuben, Dolai, Tuphan Kanti, Sinha, Dinesh Kumar, Venner, Christopher P., Garg, Mamta, Stevens, Don Ambrose, Quach, Hang, Jagannath, Sundar, Moreau, Phillipe, Levy, Moshe, Badros, Ashraf, Anderson, Larry D., Bahlis, Nizar J., Facon, Thierry, Mateos, Maria Victoria, Cavo, Michele, Chai, Yi, Arazy, Melina, Shah, Jatin, Shacham, Sharon, Kauffman, Michael G., Richardson, Paul G., Grosicki, Sebastian

Source: American journal of hematology. 96(6):708-718

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121327976.0x000001&indx=1&recIds=ETOCvdc_100121327976.0x000001

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Authors: Grosicki, Sebastian ^*, Simonova, Maryana, Spicka, Ivan, Pour, Ludek, Kriachok, Iryrna, Gavriatopoulou, Maria, Pylypenko, Halyna, Auner, Holger W, Leleu, Xavier, Doronin, Vadim, Usenko, Ganna, Bahlis, Nizar J, Hajek, Roman, Benjamin, Reuben, Dolai, Tuphan K, Sinha, Dinesh K, Venner, Christopher P, Garg, Mamta, Gironella, Mercedes, Jurczyszyn, Artur, Robak, Pawel, Galli, Monica, Wallington-Beddoe, Craig, Radinoff, Atanas, Salogub, Galina, Stevens, Don A, Basu, Supratik, Liberati, Anna M, Quach, Hang, Goranova-Marinova, Vesselina S, Bila, Jelena, Katodritou, Eirini, Oliynyk, Hanna, Korenkova, Sybiryna, Kumar, Jeevan, Jagannath, Sundar, Moreau, Phillipe, Levy, Moshe, White, Darrell, Gatt, Moshe E, Facon, Thierry, Mateos, Maria V, Cavo, Michele, Reece, Donna, Anderson, Larry D, Jr, Saint-Martin, Jean-Richard, Jeha, Jacqueline, Joshi, Anita A, Chai, Yi, Li, Lingling, Peddagali, Vishnuvardhan, Arazy, Melina, Shah, Jatin, Shacham, Sharon, Kauffman, Michael G, Dimopoulos, Meletios A, Richardson, Paul G, Delimpasi, Sosana

Source: In The Lancet 14-20 November 2020 396(10262):1563-1573

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

Authors: Walker, Brian, Mavrommatis, Konstantinos, Wardell, Christopher, Ashby, T., Bauer, Michael, Davies, Faith, Rosenthal, Adam, Wang, Hongwei, Qu, Pingping, Hoering, Antje, Samur, Mehmet, Towfic, Fadi, Ortiz, Maria, Flynt, Erin, Yu, Zhinuan, Yang, Zhihong, Rozelle, Dan, Obenauer, John, Trotter, Matthew, Auclair, Daniel, Keats, Jonathan, Bolli, Niccolo, Fulciniti, Mariateresa, Szalat, Raphael, Moreau, Phillipe, Durie, Brian, Stewart, A., Goldschmidt, Hartmut, Raab, Marc, Einsele, Hermann, Sonneveld, Pieter, San Miguel, Jesus, Lonial, Sagar, Jackson, Graham, Anderson, Kenneth, Avet-Loiseau, Herve, Munshi, Nikhil, Thakurta, Anjan, Morgan, Gareth

Source: Leukemia. 33(1):159-170

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100103847255.0x000001&indx=1&recIds=ETOCvdc_100103847255.0x000001

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma

Authors: Giralt, Sergio, Garderet, Laurent, Durie, Brian, Cook, Gordon, Gahrton, Gosta, Bruno, Benedetto, Hari, Paremesweran, Lokhorst, Henk, McCarthy, Phillip, Krishnan, Amrita, Sonneveld, Pieter, Goldschmidt, Harmut, Jagannath, Sundar, Barlogie, Bart, Mateos, Maria, Gimsing, Peter, Sezer, Orhan, Mikhael, Joseph, Lu, Jin, Dimopoulos, Meletios, Mazumder, Amitabha, Palumbo, Antonio, Abonour, Rafat, Anderson, Kenneth, Attal, Michel, Blade, Joan, Bird, Jenny, Cavo, Michele, Comenzo, Raymond, de la Rubia, Javier, Einsele, Hermann, Garcia-Sanz, Ramon, Hillengass, Jens, Holstein, Sarah, Johnsen, Hans Erik, Joshua, Douglas, Koehne, Guenther, Kumar, Shaji, Kyle, Robert, Leleu, Xavier, Lonial, Sagar, Ludwig, Heinz, Nahi, Hareth, Nooka, Anil, Orlowski, Robert, Rajkumar, Vincent, Reiman, Anthony, Richardson, Paul, Riva, Eloisa, San Miguel, Jesus, Turreson, Ingemar, Usmani, Saad, Vesole, David, Bensinger, William, Qazilbash, Muzaffer, Efebera, Yvonne, Mohty, Mohamed, Gasparreto, Christina, Gajewski, James, LeMaistre, Charles F., Bredeson, Chris, Moreau, Phillipe, Pasquini, Marcelo, Kroeger, Nicolaus, Stadtmauer, Edward

Source: In Biology of Blood and Marrow Transplantation December 2015 21(12):2039-2051

Initial treatment of transplant-eligible patients in multiple myeloma

Authors: Rosiñol, Laura, Kumar, Shaji, Moreau, Phillipe, Cavo, Michele

Source: Expert review of hematology. 7(1):43-53

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100103558203.0x000001&indx=1&recIds=ETOCvdc_100103558203.0x000001

This result is not displayed to guests.
Login for full access.

124-P HLA-E in the Brazilian population: Diversity of coding region and new variation sites

Authors: Veiga-Castelli, Luciana C., Castelli, Erick C., Mendes, Celso T., Silva, Wilson A., Faucher, Marie-Claude, Beauchemin, Karine, Roger, Michel, Moreau, Phillipe, Donadi, Eduardo A.

Source: Human immunology. 72(1):S100-S100

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100066023908.0x000001&indx=1&recIds=ETOCvdc_100066023908.0x000001

Mcl-1 and Bcl-x[sub L ] are co-regulated by IL-6 in human myeloma cells.

Authors: Puthier, Denis, Derenne, Sophie, Barillé, Sophie, Moreau, Phillipe, Harousseau, Jean-Luc, Bataille, Régis, Amiot, Martine

Source: British Journal of Haematology; Nov99, Vol. 107 Issue 2, p392-395, 4p, 2 Diagrams

Subject Terms: MULTIPLE myeloma, APOPTOSIS, CANCER cells

Salluste Ronald Syme

Authors: Moreau, Philippe, Moreau, Phillipe

Source: Annales. Histoire, Sciences Sociales, 1987 Mar 01. 42(2), 329-331.

Relation: Salluste Ronald Syme

Access URL: https://www.jstor.org/stable/27583500

This result is not displayed to guests.
Login for full access.

Thalidomide in patients with advanced multiple myeloma: a study of 83 patients--report of the intergroupe francophone du myélome (IFM).

Authors: Yakoub-Agha, Ibrahim, Attal, Michel, Dumontet, Charles, Delannoy, Valerie, Moreau, Phillipe, Berthou, Christian, Lamy, Thierney, Grosbois, Bernard, Dauriac, Charley, Dorvaux, Veronique, Bay, Jacque-Olivier, Monconduit, Matthieu, Harousseau, Jean Luc, Duguet, Corrine, Duhamel, Alain, Facon, Thierry

Source: Hematology Journal. 2002, Vol. 3 Issue 4, p185. 8p.

Subject Terms: *THALIDOMIDE, *MYELOMA proteins, *THERAPEUTICS, *PATIENTS